Brainsway (BWAY) Competitors $15.31 +0.39 (+2.61%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$15.48 +0.17 (+1.14%) As of 10/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BWAY vs. ESTA, SSII, MDXG, BBNX, INMD, IRMD, TNDM, EMBC, AXGN, and SIBNShould you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include Establishment Labs (ESTA), SS Innovations International (SSII), MiMedx Group (MDXG), Beta Bionics (BBNX), InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Embecta (EMBC), AxoGen (AXGN), and SiBone (SIBN). These companies are all part of the "medical equipment" industry. Brainsway vs. Its Competitors Establishment Labs SS Innovations International MiMedx Group Beta Bionics InMode iRadimed Tandem Diabetes Care Embecta AxoGen SiBone Brainsway (NASDAQ:BWAY) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation. Which has preferable earnings and valuation, BWAY or ESTA? Brainsway has higher earnings, but lower revenue than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsway$41.02M7.08$2.92M$0.2658.88Establishment Labs$166.02M7.23-$84.60M-$3.05-13.58 Which has more risk & volatility, BWAY or ESTA? Brainsway has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Do analysts prefer BWAY or ESTA? Brainsway presently has a consensus price target of $18.00, indicating a potential upside of 17.57%. Establishment Labs has a consensus price target of $56.50, indicating a potential upside of 36.37%. Given Establishment Labs' higher possible upside, analysts plainly believe Establishment Labs is more favorable than Brainsway.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainsway 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Establishment Labs 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 Is BWAY or ESTA more profitable? Brainsway has a net margin of 11.60% compared to Establishment Labs' net margin of -49.89%. Brainsway's return on equity of 8.97% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Brainsway11.60% 8.97% 5.65% Establishment Labs -49.89%-224.34%-25.53% Does the media prefer BWAY or ESTA? In the previous week, Establishment Labs had 1 more articles in the media than Brainsway. MarketBeat recorded 1 mentions for Establishment Labs and 0 mentions for Brainsway. Establishment Labs' average media sentiment score of 1.79 beat Brainsway's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the news media. Company Overall Sentiment Brainsway Neutral Establishment Labs Very Positive Do institutionals and insiders believe in BWAY or ESTA? 30.1% of Brainsway shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 19.0% of Brainsway shares are owned by insiders. Comparatively, 11.1% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryBrainsway beats Establishment Labs on 9 of the 16 factors compared between the two stocks. Get Brainsway News Delivered to You Automatically Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BWAY vs. The Competition Export to ExcelMetricBrainswayMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$290.48M$10.99B$6.13B$10.58BDividend YieldN/A1.87%5.65%4.69%P/E Ratio58.8922.1186.9626.71Price / Sales7.0827.54605.32131.77Price / Cash61.4025.0337.9061.31Price / Book4.633.4912.556.55Net Income$2.92M$212.45M$3.31B$277.50M7 Day Performance4.43%5.11%4.28%2.42%1 Month Performance-3.41%1.56%6.90%8.63%1 Year Performance61.16%-7.70%70.54%31.60% Brainsway Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BWAYBrainsway2.9362 of 5 stars$15.31+2.6%$18.00+17.6%+61.2%$290.48M$41.02M58.89120ESTAEstablishment Labs2.9727 of 5 stars$41.61+5.4%$56.50+35.8%-8.4%$1.14B$166.02M-13.641,018Positive NewsSSIISS Innovations InternationalN/A$6.13+6.8%N/AN/A$1.11B$20.65M0.004News CoverageGap DownMDXGMiMedx Group2.8822 of 5 stars$7.19+2.4%$12.00+66.9%+25.2%$1.04B$348.88M34.24870BBNXBeta Bionics2.334 of 5 stars$22.90+2.0%$23.33+1.9%N/A$976.34M$65.12M0.00294News CoverageAnalyst UpgradeInsider TradeINMDInMode3.0943 of 5 stars$15.01+2.1%$18.04+20.2%-4.0%$929.17M$394.82M6.08480IRMDiRadimed4.7153 of 5 stars$70.71+0.3%$72.00+1.8%+43.0%$896.67M$73.24M43.65110News CoverageInsider TradeTNDMTandem Diabetes Care4.3631 of 5 stars$13.06+3.9%$22.44+71.8%-64.8%$849.35M$940.20M-4.232,650EMBCEmbecta4.7846 of 5 stars$14.59+1.7%$19.00+30.2%+6.0%$838.68M$1.12B10.202,100Positive NewsAXGNAxoGen3.3095 of 5 stars$17.60+2.3%$26.00+47.7%+30.8%$791.42M$187.34M-175.98450Trending NewsAnalyst ForecastAnalyst RevisionSIBNSiBone3.8965 of 5 stars$14.84+1.6%$23.67+59.5%-1.2%$629.86M$167.18M-26.50350Positive News Related Companies and Tools Related Companies ESTA Alternatives SSII Alternatives MDXG Alternatives BBNX Alternatives INMD Alternatives IRMD Alternatives TNDM Alternatives EMBC Alternatives AXGN Alternatives SIBN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BWAY) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainsway Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainsway With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BWAY Stock Alerts